Advertisement
Canada markets close in 4 hours 33 minutes

  • S&P/TSX

    22,022.86
    +150.90 (+0.69%)
     

  • S&P 500

    5,066.50
    +55.90 (+1.12%)
     

  • DOW

    38,471.13
    +231.15 (+0.60%)
     

  • CAD/USD

    0.7315
    +0.0014 (+0.19%)
     

  • CRUDE OIL

    82.76
    +0.86 (+1.05%)
     

  • Bitcoin CAD

    91,256.80
    +1,263.95 (+1.40%)
     

  • CMC Crypto 200

    1,437.08
    +22.32 (+1.58%)
     

  • GOLD FUTURES

    2,333.80
    -12.60 (-0.54%)
     

  • RUSSELL 2000

    2,000.93
    +33.46 (+1.70%)
     

  • 10-Yr Bond

    4.5860
    -0.0370 (-0.80%)
     

  • NASDAQ

    15,689.09
    +237.79 (+1.54%)
     

  • VOLATILITY

    16.27
    -0.67 (-3.96%)
     

  • FTSE

    8,043.42
    +19.55 (+0.24%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6834
    -0.0016 (-0.23%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

Is HealthEquity (HQY) a Great Growth Stock?

Zacks Equity Research
Updated

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

One such company that might be well-positioned for future earnings growth is HealthEquity, Inc. HQY. This firm, which is in the Medical Services industry, saw EPS growth of 22.7% last year, and is looking great for this year too.

In fact, the current growth estimate for this year calls for earnings-per-share growth of 42.3%. Furthermore, the long-term growth rate is currently an impressive 32.5%, suggesting pretty good prospects for the long haul.

HealthEquity, Inc. Price and Consensus

HealthEquity, Inc. Price and Consensus | HealthEquity, Inc. Quote

ADVERTISEMENT

And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 8.6%. Thanks to this rise in earnings estimates, HQY has a Zacks Rank #2 (Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HQY. Not only does it have double-digit earnings growth prospects, but its impressive Zacks Rank suggests that analysts believe better days are ahead for HQY as well.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>
 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research